I played around with some basic numbers....
Assuming 25% QoQ increase from the analytical division:
2017 CY forecast would give us around $1.2M
Add another $166k from PromarkerD DR royalties so we land at around $1.4M.
General Opex for R&D/staff/admin/marketing etc is around $3.5M (assuming cost stay as reported in Q1)
If R&D stays at around $450k the tax rebate will be around $780k so adding that to our $1.4M will see us around $2.2M potential close of CY 2018.Hopefully the on-going investments into R&D will pay off soon enough, if we land more PromarkerD sales this year that would be fantastic and hopefully analytical service continues to see growth.
I played around with some basic numbers.... Assuming 25% QoQ...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $49.05M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 29.0¢ | $51.47K | 171.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 56262 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 27300 | 1 |
View Market Depth
| Last trade - 11.08am 27/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |